Beryllium

major histocompatibility complex, class II, DP beta 1 ; Homo sapiens







33 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34535537 HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease. 2022 Feb 2
2 28079614 The role of gene-environment interplay in occupational and environmental diseases: current concepts and knowledge gaps. 2017 Mar 1
3 21186201 HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity. 2011 Jul 1
4 21460389 Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. 2011 Nov 1
5 21471109 Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. 2011 Jun 15 3
6 22997873 Work-related lung diseases. 2011 2
7 20356827 Crystal structure of HLA-DP2 and implications for chronic beryllium disease. 2010 Apr 20 1
8 19191908 Role of high-affinity HLA-DP specific CLIP-derived peptides in beryllium binding to the HLA-DPGlu69 berylliosis-associated molecules and presentation to beryllium-sensitized T cells. 2009 Sep 5
9 18317020 Immunology of chronic beryllium disease. 2008 Apr 1
10 19221964 Metal-induced diffuse lung disease. 2008 Dec 1
11 17927685 BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. 2007 Dec 1
12 16607200 Ethical considerations in testing workers for the -Glu69 marker of genetic susceptibility to chronic beryllium disease. 2006 Apr 1
13 16697706 T cell recognition in chronic beryllium disease. 2006 Nov 1
14 16054169 Immunogenetic factors in beryllium sensitization and chronic beryllium disease. 2005 Dec 30 13
15 16098233 Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69. 2005 Aug 14 4
16 16099719 Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. 2005 Oct 1
17 16272364 Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. 2005 Nov 15 3
18 14975942 Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. 2004 Jul 1
19 15273960 The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. 2004 Aug 4
20 12615603 HLA-DPB1 and chronic beryllium disease: a HuGE review. 2003 Mar 1 5
21 12620668 Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study. 2003 Feb 1 2
22 14617028 Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity. 2003 Dec 1
23 14630515 Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease. 2003 Nov 2
24 14662898 Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. 2003 Dec 15 2
25 12449171 HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. 2002 Nov 1
26 12516537 Genetic and exposure risks for chronic beryllium disease. 2002 Dec 1
27 11207315 HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. 2001 Mar 1 2
28 11370939 Chronic beryllium disease: a hypersensitivity disorder. 2001 May 1
29 11414740 Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP. 2001 Jul 1
30 11551429 Beryllium sensitivity is linked to HLA-DP genotype. 2001 Aug 13 4
31 11050177 Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. 2000 Nov 7 4
32 10415070 Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. 1999 Aug 1 3
33 9655715 Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. 1998 Jul 1